Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2-Reference-Cited by-全球学者库

Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2

Published:2020-11-05 Issue:1 Volume:253 Page:106-118
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Liu Qiuli¹,Pang Jian¹,Wang Lin‐ang¹,Huang Zhuowei¹,Xu Jing¹,Yang Xingxia¹,Xie Qiubo¹,Huang Yiqiang¹,Tang Tang¹,Tong Dali¹,Liu Gaolei¹,Wang Luofu¹,Zhang Dianzheng²,Ma Qiang³,Xiao Hualiang³,Lan Weihua¹,Qin Jun¹⁴,Jiang Jun¹^ORCID

Affiliation:

1. Department of Urology, Institute of Surgery Research Daping Hospital, Army Medical University Chongqing PR China

2. Department of Bio‐Medical Sciences Philadelphia College of Osteopathic Medicine Philadelphia PA USA

3. Department of Pathology, Institute of Surgery Research Daping Hospital, Army Medical University Chongqing PR China

4. CAS Key Laboratory of Tissue Microenvironment and Tumor, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Nutrition and Health Sciences Chinese Academy of Sciences, University of Chinese Academy of Sciences Shanghai PR China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.5557

Reference39 articles.

1. Low PSA Metastatic Androgen– Independent Prostate Cancer

2. Neuroendocrine Differentiation in Prostatic Carcinomas: Histogenesis, Biology, Clinical Relevance, and Future Therapeutical Perspectives

3. Aggressive Variants of Castration-Resistant Prostate Cancer